Nanomedicine News

RSS

Scientists Genetically Modify White Blood Cells to Treat Degenerative Neurological Disorders

As a potential treatment for Parkinson's disease, scientists at the University of North Carolina at Chapel Hill have created smarter immune cells that produce and deliver a healing protein to the brain while also teaching neurons to begin making the protein for themselves.

14 Sep 2015

Microfluidics Technology-Based Lab-on-a-Chip Device Could Reduce Cost of Sophisticated Tests for Diseases

Rutgers engineers have developed a breakthrough device that can significantly reduce the cost of sophisticated lab tests for medical disorders and diseases, such as HIV, Lyme disease and syphilis.

14 Sep 2015

Translational Grant for Interaction Study of Laser Radiation with Circulating Tumor Cells and Melanin Nanoparticles

University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc., was awarded a $1.7 million grant by the National Cancer Institute for clinical testing of a new technology called Theranostics, which is an integration of early diagnosis and treatment of melanoma.

14 Sep 2015

Full Data Set from Novavax RSV F Vaccine Clinical Trial Published in Journal of Infectious Disease

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the full data set from its clinical trial of the RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in women of childbearing age (18-35 years) were published in the Journal of Infectious Disease. The Company previously announced top-line results from the trial.

From Novavax Inc. 14 Sep 2015

Celsion Provides Update on Development of GEN-1 for Ovarian and Brain Cancer

Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies for the treatment of cancer and other difficult-to-treat diseases, announced today that the Company has completed the integration of its June 2014 acquisition of EGEN, Inc. and has provided an update on its clinical development plans for GEN-1, the Company's DNA-based immunotherapy for the localized treatment of ovarian and brain cancer.

10 Sep 2015

Dosing Commences in BIND Therapeutics’ BIND-014 iNSITE 2 Trial in Patients with Four Tumor Histologies

BIND Therapeutics, Inc., a clinical-stage nanomedicine company developing targeted and programmable therapeutics called AccurinsTM, today announced that patient dosing is underway in the iNSITE 2 trial, a global, phase 2, two-stage clinical trial of BIND-014 in patients with four tumor histologies.

10 Sep 2015

Tiny ‘Nanopore’ Scanners for Early Diagnosis of Cancer Biomarkers

Using tiny “nanopore” scanners that can detect individual DNA molecules, Professor Amit Meller and colleagues are on the hunt for biological markers in cancer cells that may help clinicians diagnose colorectal and lung cancers at their earliest stages.

10 Sep 2015

Nanoporous Gold Sponge Detects Pathogens Faster

A team of researchers from University of California, Davis has proved that nucleic acids can be detected using nanoporous gold, a unique sensor coating material, in a mixture containing other biomolecules, thus beating most of the currently used detectors.

8 Sep 2015

Multiphoton Microscope Reveals How Immune Cells Engage in Coordinated Behavior to Wipe Out Flu Viruses

Much like birds fly in flocks to conserve energy, dolphins swim in pods to mate and find food, and colonies of ants create complex nests to protect their queens, immune cells engage in coordinated behavior to wipe out viruses like the flu.

7 Sep 2015

Novel Technique Helps Produce Amorphous Nanoparticles for Better Drug Efficiency

Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.

3 Sep 2015

Nanomedicine News

Scientists Genetically Modify White Blood Cells to Treat Degenerative Neurological Disorders

Microfluidics Technology-Based Lab-on-a-Chip Device Could Reduce Cost of Sophisticated Tests for Diseases

Translational Grant for Interaction Study of Laser Radiation with Circulating Tumor Cells and Melanin Nanoparticles

Full Data Set from Novavax RSV F Vaccine Clinical Trial Published in Journal of Infectious Disease

Celsion Provides Update on Development of GEN-1 for Ovarian and Brain Cancer

Dosing Commences in BIND Therapeutics’ BIND-014 iNSITE 2 Trial in Patients with Four Tumor Histologies

Tiny ‘Nanopore’ Scanners for Early Diagnosis of Cancer Biomarkers

Nanoporous Gold Sponge Detects Pathogens Faster

Multiphoton Microscope Reveals How Immune Cells Engage in Coordinated Behavior to Wipe Out Flu Viruses

Novel Technique Helps Produce Amorphous Nanoparticles for Better Drug Efficiency

Laser-Induced Graphene for Printable and Biomedical Applications

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Co-Solvent-Driven Laser Assembly of Gold Nanorods

Cigarette Waste as a Source for Sustainable Supercapacitors

Novel Technique Dramatically Increases Graphene's Elasticity

Breaking Barriers in Thin-Film Deposition with ATLANT 3D’s DALP Technology

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

Sponsored Content

Unlocking Material Behavior at the Microscale Using Nanoindentation

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination